Team develops a rapid test to measure immunity to SARS-CoV-2

Mount Sinai researchers have developed a rapid blood assay that measures the magnitude and duration of someone's immunity to SARS-CoV-2, the virus that causes COVID-19. This test will allow large-scale monitoring of the population's ...

Investigating a hospital superbug's resistance power

Treatment of severe infections caused by pathogenic bacteria relies on "last resort" antibiotics, but rising resistance by "superbugs" to most clinically approved drugs leaves patients exposed to possible fatalities.

New discovery may hold key to fighting deadly infections

Centenary Institute research has revealed new insight into tackling mycobacterial infections which are responsible for chronic diseases that include tuberculosis (TB), leprosy and serious skin ulcerations.

Propagation of parasite in toxoplasmosis host cell stopped

Toxoplasmosis is one of the most widespread zoonoses worldwide. It is an infectious disease that can be transmitted from cats to humans. People can also become infected by consuming raw or undercooked meat. Infection is particularly ...

Blocking spike captors to counter COVID

Despite the effectiveness of vaccination campaigns worldwide, the threat posed by COVID-19 still exists. First of all, a new SARS-CoV-2 variant could very well emerge that may not respond to current vaccines. Secondly, the ...

RNA binding proteins help T cells pick their weapons before battle

Scientists at the Babraham Institute have shown that two RNA binding proteins hold the key to a stronger immune response to influenza in mice. Their findings, published today in Nature Communications, reveal that the absence ...

page 10 from 40